08.03.2011 • News • Actelion • Elliott Advisors

Rudolf Maag Gives Backing to Actelion

Actelion, Europe's largest biotech company, has the backing of Rudolf Maag, one its largest shareholders, a spokeswoman for Maag said on Monday.

The company is coming under pressure from hedge fund activist Elliott Advisors ahead of the group's annual general meeting in May.
Elliott, Actelion's biggest shareholder with a near 6% stake, is dissatisfied with the group's performance and is pushing Actelion to consider selling itself.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature